Triazolam Tablet
Product Images NDC 59762-3718

5 FDA label images from Mylan Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Triazolam (NDC 59762-3718). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Triazolam 01)

Chemical Structure (Triazolam 01)
Chemical structure of triazolam, showing the arrangement of atoms and bonds including two chlorine-substituted phenyl rings and a triazolo ring system.*
FDA Label Image

Logo (Triazolam 02)

Logo (Triazolam 02)
This image shows a label indicating the product is a Greenstone® Brand distributed by Greenstone LLC, Peapack, NJ 07977. It is associated with Triazolam tablets, a human prescription drug by Mylan Pharmaceuticals Inc., available in .125 mg and .25 mg oral tablet strengths.*
FDA Label Image

Logo (Triazolam 02a)

Logo (Triazolam 02a)
This image shows a product label section for a pharmaceutical drug distributed by Greenstone LLC, located in Peapack, New Jersey. The Greenstone Brand logo is visible at the top.*
FDA Label Image

Principal Display Panel (0.125 mg Tablet Bottle Label)

Principal Display Panel (0.125 mg Tablet Bottle Label)
Label for Triazolam tablets USP 0.125 mg by Greenstone LLC. The label indicates a package of 10 tablets, controlled room temperature storage, and prescription only. The product is classified as a Schedule IV controlled substance with NDC 59762-3717-4 and includes a barcode and dispensing instructions.*
FDA Label Image

Principal Display Panel (0.25 mg Tablet Bottle Label)

Principal Display Panel (0.25 mg Tablet Bottle Label)
Label for Triazolam tablets, USP 0.25 mg oral tablets in a 10 tablet package by Mylan Pharmaceuticals Inc. The label indicates the drug is Schedule IV, distributed by Greenstone LLC, and provides storage instructions at controlled room temperature 20° to 25°C (68° to 77°F). Dosage and use instructions advise referring to the accompanying prescribing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.